Literature DB >> 28298516

Precision Medicine in Breast Cancer.

Teresa G Odle.   

Abstract

Breast cancer care has improved markedly in recent decades, but new advancements in diagnosis and treatment depend on translating genomics and precision medicine into clinical care. This article discusses the basics of genomics, breast cancer biomarkers and subtypes, and the effects of genomic advancements on future breast cancer diagnosis, treatment, and survival. The article also presents challenges related to introducing precision medicine into cancer care and the role of imaging in breast cancer diagnosis and treatment in precision medicine. ©2017 American Society of Radiologic Technologists.

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28298516

Source DB:  PubMed          Journal:  Radiol Technol        ISSN： 0033-8397


  23 in total

1.  Software Workflows and Infrastructures for Precision Oncology.

Authors:  Waleed Osman; Alessandro Laganà
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 2.622

2.  A Proposed TUSC7/miR-211/Nurr1 ceRNET Might Potentially be Disturbed by a cer-SNP rs2615499 in Breast Cancer.

Authors:  Rasoul Abdollahzadeh; Asaad Azarnezhad; Sahereh Paknahad; Yaser Mansoori; Maryam Pirhoushiaran; Khaled Kanaani; Neda Bafandeh; Davood Jafari; Javad Tavakkoly-Bazzaz
Journal:  Biochem Genet       Date:  2022-03-17       Impact factor: 1.890

3.  Expression and prognostic value of ratios of platelet lymphocyte, neutrophil lymphocyte and lymphocyte monocyte in breast cancer patients.

Authors:  Deba Song; Xiaoxu Li; Xiaojian Zhang
Journal:  Am J Transl Res       Date:  2022-05-15       Impact factor: 3.940

4.  Integrated Analysis of Genomic and Transcriptomic Profiles Identified the Role of GTP Binding Protein-4 (GTPBP4) in Breast Cancer.

Authors:  Yiming Hu; Jiaheng Xie; Liang Chen; Qikai Tang; Wei Wei; Wenfeng Lin; Wang Du; Tinghong Xiang; Lu Yin; Jing Ji
Journal:  Front Pharmacol       Date:  2022-06-16       Impact factor: 5.988

5.  MiR-379-5p inhibits the proliferation, migration, and invasion of breast cancer by targeting KIF4A.

Authors:  Ke Yang; Danyang Li; Weihui Jia; Yanmei Song; Ningxin Sun; Jiemin Wang; Hongli Li; Chonggao Yin
Journal:  Thorac Cancer       Date:  2022-05-24       Impact factor: 3.223

6.  Patterns of Chest Wall Recurrence and Suggestions on the Clinical Target Volume of Breast Cancer: A Retrospective Analysis of 121 Postmastectomy Patients.

Authors:  Lin-Wei Wang; Li Li; Hong-Yan Zhang; Yuan-Yuan Chen; Ya-Hua Zhong
Journal:  Cancer Manag Res       Date:  2020-07-17       Impact factor: 3.989

7.  Identification of hub genes in triple-negative breast cancer by integrated bioinformatics analysis.

Authors:  Li-Min Wei; Xin-Yang Li; Zi-Ming Wang; Yu-Kun Wang; Ge Yao; Jia-Hao Fan; Xin-Shuai Wang
Journal:  Gland Surg       Date:  2021-02

8.  Clinical Potential of lncRNA PPP1R26-AS1 in Breast Cancer and Its Contribution to Cancer Progression.

Authors:  Shuping Zhou; Shaoli Zhang; Hui Zhang; Junxia Ma; Huangzhen Dai; Lili Qu; Meixiang Zhou
Journal:  Mol Biotechnol       Date:  2022-01-22       Impact factor: 2.695

9.  dNLR and TILS can be used as indicators for prognosis and efficacy evaluation of neo-adjuvant chemotherapy in breast cancer.

Authors:  Xiaorui Wang; Weipeng Zhao; Lihong He; Shuling Wang; Weidong Li; Jing Wang; Zhongsheng Tong
Journal:  Am J Transl Res       Date:  2021-11-15       Impact factor: 4.060

10.  Analysis of Heterozygous BRCA1 5382ins Founder Mutation in a Cohort of Egyptian Breast Cancer Female Patients Using Pyrosequencing Technique.

Authors:  Salwa H Gomaa Mogahed; Yasser S Hamed; Yassmin E Ibrahim Moursy; Marwa H Mahomoud Saied
Journal:  Asian Pac J Cancer Prev       Date:  2020-02-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.